Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel.
Richard HansenSusanna MeadeRobert Mark BeattieMarcus Karl-Heinz AuthNicholas M CroftPhilip DaviesDavid DevadasonConor DohertyJenny EpsteinLucy HowarthFevronia KiparissiRafeeq MuhammedVinay ShivamurthyChristine H SprayMichael P StantonFranco TorrenteArun UrsDavid C WilsonPeter M IrvingMark A SamaanJochen KammermeierPublished in: Gut (2020)
Our COVID-19-specific adaptations to paediatric ASC guidelines using a RAND panel generally support existing recommendations, particularly the use of corticosteroids and escalation to infliximab, irrespective of SARS-CoV-2 status. Consideration of routine prophylactic anticoagulation was recommended.
Keyphrases
- sars cov
- clinical practice
- intensive care unit
- respiratory syndrome coronavirus
- emergency department
- high intensity
- coronavirus disease
- liver failure
- ulcerative colitis
- drug induced
- venous thromboembolism
- atrial fibrillation
- respiratory failure
- open label
- early onset
- nlrp inflammasome
- aortic dissection
- randomized controlled trial
- hepatitis b virus